Abstract

In-Depth Evaluation of a Case of Presumed Myocarditis After the Second Dose of COVID-19 mRNA Vaccine.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease: A Viewpoint on the Potential Influence of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on Onset and Severity of Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
Zheng Huang ... Jiagao Lv
Journal of the American Heart Association | VOL. 9
Zheng Huang, et. al.Zheng Huang ... Jiagao Lv
01 Apr 2020
In high-risk adults, the Moderna vaccine had 94% efficacy against COVID-19 ≥14 d after the 2nd dose.
Zain Chagla
Annals of internal medicine | VOL. 174
Zain ChaglaZain Chagla
01 Mar 2021
Immunization Update 2021
Miranda Wilhelm
Pharmacy Today | VOL. 27
Miranda WilhelmMiranda Wilhelm
01 Aug 2021
COVID-19: What do we know?
Eser Tufekci ... James Mah
American Journal of Orthodontics & Dentofacial Orthopedics | VOL. 158
Eser Tufekci, et. al.Eser Tufekci ... James Mah
21 Sep 2020
View more papers

More From: Circulation

Paper Title
Journal
Date
Author
Cardiovascular Magnetic Resonance Radiomics to Identify Components of the Extracellular Matrix in Dilated Cardiomyopathy.
Shiro Nakamori ... Reza Nezafat
Circulation | VOL. -
Shiro Nakamori, et. al.Shiro Nakamori ... Reza Nezafat
29 May 2024
Evaluation and Management of Chronic Heart Failure in Children and Adolescents With Congenital Heart Disease: A Scientific Statement From the American Heart Association.
Shahnawaz Amdani ... Daphne T Hsu
Circulation | VOL. -
Shahnawaz Amdani, et. al.Shahnawaz Amdani ... Daphne T Hsu
29 May 2024
Evolving Cardiac Safety in Drug Discovery: Time for Immunology Integration.
Jose M Vicencio ... Amy Pointon
Circulation | VOL. 149
Jose M Vicencio, et. al.Jose M Vicencio ... Amy Pointon
28 May 2024
Response by Henriksen et al Regarding Article, "Multicenter, Prospective, Randomized Controlled Trial of High-Sensitivity Cardiac Troponin I-Guided Combination Angiotensin Receptor Blockade and Beta-Blocker Therapy to Prevent Anthracycline Cardiotoxicity: The Cardiac CARE Trial".
Peter A Henriksen ... Ninian N Lang
Circulation | VOL. 149
Peter A Henriksen, et. al.Peter A Henriksen ... Ninian N Lang
28 May 2024
View more papers